[Neurological toxicity from pentavalent antimonials during the treatment of visceral leishmaniasis].
Laguna del Estal
P
P
Calabrese
S
S
Zabala
J A
JA
Martín
T
T
D000328:Adult; D000965:Antimony / Q000009:adverse effects*; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009122:Muscle Hypertonia / Q000139:chemically induced*; D014202:Tremor / Q000139:chemically induced*
D000981:Antiprotozoal Agents; D000965:Antimony
Toxicidad neurológica por antimoniales pentavalentes durante el tratamiento de la leishmaniasis visceral.